Now is the time for Obama to beat back the congressional hawks taking aim at the Iran deal.
One of Europe's biggest countries is on the verge of economic collapse. The second in our series of Lab Reports on Ukraine.
Obama needs to consult Congress before he authorizes offensive military action in Afghanistan after 2014.
How one woman's fate is derailing Ukraine's European dream.
A U.S. ally is treating a would-be nation as a prison camp -- and we're doing nothing about it.
Why Israel can no longer afford to rebuff global norms pertaining to weapons of mass destruction.
Congressmen cry foul over currency intervention -- until the U.S. does it.
In the wake of Typhoon Haiyan, the United States has gained some ground at China's expense.
The world is profoundly divided over gay rights -- and it's going to get worse before it gets better.
It’s time for the world’s largest democracy to start promoting human rights.
Some pundits are celebrating the effort to get rid of Bashar al-Assad's chemical weapons. But if this is progress, what does failure look like?
The U.S. ambassador to China speaks to Foreign Policy.
Americans are still willing to forgive the NSA's intrusions, but are U.S. friends abroad?
Lust, sloth, and wrath are even worse when states do them -- right, Machiavelli?
Bosnia's current constitution leaves some people unrepresented. It's time to move away from ethnicity and toward citizenship.
As they gear up for the 2014 Winter Olympics, young Russians find themselves exercising some little-used facial muscles.
Will the self-inflicted political wound of the U.S. government shutdown ever heal?
Smugglers, shipwrecks, and the harrowing, tragic journey of Syrian refugees trying to get to Sweden.
America's using front companies, break-in artists, and hacktivists to spy on everyone -- and only North Korea seems able to resist.
Meet the social worker turned nuclear negotiator who's trying to keep Iran from getting the bomb.
Why can't we get rid of nukes the same way we got rid of chemical weapons?
The British Commonwealth is stirring up unaccustomed controversy -- and that's a good thing.